We have located links that may give you full text access.
A modified dose-response model that describes the relationship between haemagglutination inhibition titre and protection against influenza infection.
Journal of Applied Microbiology 2018 January
AIMS: Develop a model for quantifying the risk of an adverse human response to influenza virus infection as a function of exposure dose and pre-exposure antibody titre level.
METHODS AND RESULTS: We evaluated the relationship between haemagglutination inhibition (HI) titre (as a measure of specific antibody response) and protection against influenza infection and modelled this relationship by incorporating HI titre as a variable into dose-response models. Using a maximum likelihood estimation approach, the resulting model was capable of providing statistically acceptable fits to most available data.
CONCLUSIONS: The incorporated HI titre dependency in the model quantifies the protective effect of antibody titre. The modelling can be used to predict the protection effectiveness associated with elevated HI titre levels post vaccination to different levels of exposures.
SIGNIFICANCE AND IMPACT OF THE STUDY: The study incorporates HI titre level as a variable into a dose-response model for influenza infection. The approaches developed in this study could be used to evaluate other factors associated with the predictability of HI titre or other surrogate endpoints for influenza vaccines.
METHODS AND RESULTS: We evaluated the relationship between haemagglutination inhibition (HI) titre (as a measure of specific antibody response) and protection against influenza infection and modelled this relationship by incorporating HI titre as a variable into dose-response models. Using a maximum likelihood estimation approach, the resulting model was capable of providing statistically acceptable fits to most available data.
CONCLUSIONS: The incorporated HI titre dependency in the model quantifies the protective effect of antibody titre. The modelling can be used to predict the protection effectiveness associated with elevated HI titre levels post vaccination to different levels of exposures.
SIGNIFICANCE AND IMPACT OF THE STUDY: The study incorporates HI titre level as a variable into a dose-response model for influenza infection. The approaches developed in this study could be used to evaluate other factors associated with the predictability of HI titre or other surrogate endpoints for influenza vaccines.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app